Recent Blog Articles

Fall shots: Who's most vulnerable to RSV, COVID, and the flu?

Got immunity? Thank your thymus

Easy ways to shop for healthful, cost-conscious foods

When — and how — should you be screened for colon cancer?

7 organs or glands you may do just fine without

How to help your child get the sleep they need

What color is your tongue? What's healthy, what's not?

Immune boosts or busts? From IV drips and detoxes to superfoods

The new RSV shot for babies: What parents need to know

Dealing with thick, discolored toenails

Aneesh Singhal, MD
Contributor
Aneesh B. Singhal, MD, is Vice-Chair of Neurology Quality and Safety at Massachusetts General Hospital and Associate Professor of Neurology at Harvard Medical School in Boston, USA. He is a Board Certified Neurologist, Vascular Neurologist and, Neurosonologist. He serves on the Board of Trustees of the Partners Continuing Care and Spaulding Rehabilitation Network, is advisor to Partners HealthCare International and Neurology Foundation India. He is an elected Fellow to the American Neurological Association, the American Academy of Neurology, and the American Heart Association, and Past President of the Association of Indian Neurologists in USA.
Dr. Singhal’s areas of research include stroke clinical trials, stroke in young adults, cerebral arteriopathies, advanced brain imaging for acute ischemic stroke, and stroke neuroprotection. He is internationally recognized for his work on characterizing the reversible cerebral vasoconstriction syndrome (RCVS) and cerebral vasculitis. He is Deputy Principal Investigator of the New England Regional Coordinating Center (NERCC) for the NIH StrokeNet. He has served as the Principal Investigator of the NIH funded Indo-US Collaborative Stroke Project, the NIH funded Phase 2 trial of Normobaric Oxygen Therapy in Acute Stroke, and as site PI of several Industry funded stroke clinical trials. Dr. Singhal has authored or co-authored over 200 articles and book chapters.